Ardea Biosciences, Inc. (RDEA) Reports Q1 Loss of $1.25/Share
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Price: $31.96 --0%
Financial Fact:
General and administrative: 5.69M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
General and administrative: 5.69M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q1 EPS of ($1.25), $0.27 worse than the analyst estimate of ($0.98). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $3 million.
For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.
For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- BofA Securities Reiterates Buy Rating on Meta Platforms Inc. (META)
- Lilly to buy Merida Biosciences for up to $2.875 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
